drugset / Trial / NCT03958721
Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm, prospective, non-randomized, feasibility study evaluating concurrent capecitabine-radiotherapy in participants with Resistant Breast Cancer.
Timeline
- Start
- 2019-07-18
- Primary completion
- 2023-10-26
- Completion
- 2023-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |